NCT00020904View on ClinicalTrials.gov

BMS-247550 in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Breast Cancer
Interventions
DRUG

ixabepilone

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

10032

Herbert Irving Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00020904 - BMS-247550 in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter